A.R.T. Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-22,100
Closed -$2.45M 1588
2019
Q2
$2.45M Buy
+22,100
New +$2.6M 0.14% 193
2019
Q1
Sell
-59,800
Closed -$6.92M 1471
2018
Q4
$6.92M Buy
59,800
+27,600
+86% +$3.08M 0.44% 18
2018
Q3
$3.46M Sell
32,200
-7,100
-18% -$710K 0.16% 159
2018
Q2
$3.35M Sell
39,300
-84,600
-68% -$6.95M 0.14% 203
2018
Q1
$9.59M Buy
+123,900
New +$9.97M 0.38% 32
2017
Q4
Sell
-21,700
Closed -$1.86M 1540
2017
Q3
$1.86M Sell
21,700
-59,500
-73% -$4.88M 0.09% 307
2017
Q2
$6.68M Buy
81,200
+500
+0.6% +$40.8K 0.35% 42
2017
Q1
$6.79M Buy
+80,700
New +$6.46M 0.31% 52
2015
Q4
Sell
-105,796
Closed -$8.85M 1605
2015
Q3
$8.85M Buy
+105,796
New +$8.93M 0.33% 57
2014
Q1
Sell
-116,315
Closed -$5.93M 1452
2013
Q4
$5.93M Buy
116,315
+68,055
+141% +$3.41M 0.32% 55
2013
Q3
$2.43M Sell
48,260
-63,858
-57% -$3.34M 0.13% 220
2013
Q2
$5.51M Buy
+112,118
New +$6.1M 0.18% 162

Other funds holding LLY

A.R.T. Advisors's LLY Position: Q3 2019 in Review

A.R.T. Advisors sold out of Eli Lilly (LLY) in Q3 2019, closing a stake of 22,100 shares — an estimated $2.45M sold.

A.R.T. Advisors first reported a position in LLY in Q2 2013 and held it in 12 quarters. The position peaked at $9.59M in Q1 2018. 1,524 funds tracked by Wall St. Rank hold LLY as of Q3 2019.

  • A.R.T. Advisors reported no remaining Eli Lilly position as of Q3 2019 after selling out during the quarter.
  • A.R.T. Advisors sold 22,100 Eli Lilly shares in Q3 2019, an estimated $2.45M.
  • A.R.T. Advisors first reported a position in Eli Lilly in Q2 2013 and held it in 12 quarters.
  • A.R.T. Advisors's Eli Lilly position peaked at $9.59M in Q1 2018.
  • 1,524 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.